Basic Study
Copyright ©The Author(s) 2021.
World J Gastrointest Oncol. Dec 15, 2021; 13(12): 2088-2100
Published online Dec 15, 2021. doi: 10.4251/wjgo.v13.i12.2088
Table 7 Microbiome comparison in patients with pancreatic disease
Benign pancreatic diseases (n = 16)Pancreatic cancer (n = 9)P value
Bacteroides, %, median (range)2.1 (0-26.1)5.8 (0-46.4)0.17
Bifidobacterium, %, median (range)0 (0-0.5)0.48 (0-4.5)0.03
Clostridium cluster IV, %, mean ± SD4.0 ± 3.33.6 ± 2.90.76
Clostridium cluster IX, %, mean ± SD5.3 ± 3.66.4 ± 5.20.57
Clostridium cluster XI, %, median (range)0 (0-0)0 (0-0)
Clostridium cluster XVIII, %, median (range)1.4 (0-3.9)3.0 (0.8-14.9)0.04
Clostridium subcluster XIVa, %, median (range)3.8 (0-21.4)6.0 (2.9-13.7)0.32
Lactobacillales, %, mean ± SD68.4 ± 19.359.7 ± 20.40.3
Prevotella, %, median (range)4.2 (2.5-20.4)4.0 (1.5-6.3)0.3
Others, %, median (range)2.0 (0-18.3)0.3 (0-11.0)0.3